Ticker: RGNX

Company: REGENXBIO Inc.

Person: Craig Malzahn, officer

Transaction date: Jan. 2, 2026

Reporting date: Jan. 6, 2026

Average share price: 14.4

Sold 1238.0 shares for 17827.2